Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Hoover

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature|September 8, 2020
Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypesElizabeth J Adams, Wouter R Karthaus, Elizabeth Hoover, et al.
Nature|June 28, 2019
FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypesElizabeth J Adams, Wouter R Karthaus, Elizabeth Hoover, et al.
Science (New York, N.Y.)|January 7, 2017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancerPing Mu, Zeda Zhang, Matteo Benelli, et al.
Journal of Medical Genetics|September 8, 2021
Biallelic variants of <i>ATP13A3</i> cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortalityRajiv D Machado, Carrie L Welch, Matthias Haimel, et al.
Blood Cancer Discovery|November 15, 2021
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic MalignanciesDavid J Chung, Gunjan L Shah, Sean M Devlin, et al.
Cancer Cell|March 30, 2020
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin DysregulationZeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature|September 8, 2020
Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypesElizabeth J Adams, Wouter R Karthaus, Elizabeth Hoover, et al.
Nature|June 28, 2019
FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypesElizabeth J Adams, Wouter R Karthaus, Elizabeth Hoover, et al.
Science (New York, N.Y.)|January 7, 2017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancerPing Mu, Zeda Zhang, Matteo Benelli, et al.
Journal of Medical Genetics|September 8, 2021
Biallelic variants of <i>ATP13A3</i> cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortalityRajiv D Machado, Carrie L Welch, Matthias Haimel, et al.
Blood Cancer Discovery|November 15, 2021
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic MalignanciesDavid J Chung, Gunjan L Shah, Sean M Devlin, et al.
Cancer Cell|March 30, 2020
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin DysregulationZeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Pageof 3